Hollow mesoporous Prussian blue nanozymes alleviate doxorubicin-induced cardiotoxicity by restraining oxidative stress associated with Nrf2 signaling
Journal of Colloid and Interface Science · 2025-05 · 686 · 1074-1088
DOI: 10.1016/j.jcis.2025.02.033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Colloid and Interface Science, 2025-05. Verfasst von Fang Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang Province 325000, PR China. Hauptthemen laut MEDLINE: Doxorubicin, Oxidative Stress, Ferrocyanides, Nanoparticles. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Medical Science and Technology Project of Zhejiang Province, Zhejiang Province Natural Science Foundation, Shaoxing Science Technology Bureau.
Abstract (Originalsprache)
Doxorubicin-induced cardiomyopathy (DIC) is a toxic side effect that cannot be ignored during chemotherapy for malignant tumors. In this work, we synthesized a novel nano-chemotherapeutic drug based on Prussian blue nanozyme to alleviate DIC. Hollow mesoporous Prussian blue (HmPB) nanoparticles were used as a carrier to load doxorubicin (DOX) through electrostatic adsorption and obtain a novel chemotherapy drug, HmPB(DOX). In vivo and in vitro chemotherapy efficacy and acute toxicity evaluation experiments were conducted. The results suggest that HmPB(DOX) exhibits pH-responsive characteristics and minimizes the release of DOX from within HmPB(DOX) in cardiomyocytes. However, in the acidic tumor microenvironment, the release of DOX from HmPB(DOX) is notably enhanced. More importantly, HmPB(DOX) possesses excellent antioxidant enzyme activity, effectively clearing DOX-induced reactive oxygen species (ROS) and alleviating oxidative stress in cardiomyocytes. Doxorubicin is pivotal in the chemotherapy of malignant tumors. This study presents novel insights for mitigating the toxic and side effects of DOX, offering new strategies to enhance tolerance to chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang Province 325000, PR China.
- Laboratory of Nanomedicine, Medical Science Research Center, School of Medicine, Shaoxing University, Shaoxing City, Zhejiang Province 312000, PR China; School of Life and Environmental Sciences, Shaoxing University, Sh…
- Laboratory of Nanomedicine, Medical Science Research Center, School of Medicine, Shaoxing University, Shaoxing City, Zhejiang Province 312000, PR China.
- Department of Clinical Laboratory, Shaoxing Second Hospital, Shaoxing City, Zhejiang Province 312000, PR China.
- The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang Province 325000, PR China. Electronic address: linyinuo@wmu.edu.cn.
- Laboratory of Nanomedicine, Medical Science Research Center, School of Medicine, Shaoxing University, Shaoxing City, Zhejiang Province 312000, PR China. Electronic address: yzs@usx.edu.cn.
Förderung
- Medical Science and Technology Project of Zhejiang Province
- Zhejiang Province Natural Science Foundation
- Shaoxing Science Technology Bureau
Zitieren
APA
Wang, F., Wang, K., Fang, B., Geng, S., Li, Y., Qian, H., Lin, Y., & Yu, Z. (2025). Hollow mesoporous Prussian blue nanozymes alleviate doxorubicin-induced cardiotoxicity by restraining oxidative stress associated with Nrf2 signaling. Journal of Colloid and Interface Science, 686, 1074-1088. https://doi.org/10.1016/j.jcis.2025.02.033
Vancouver
Wang F, Wang K, Fang B, Geng S, Li Y, Qian H, et al. Hollow mesoporous Prussian blue nanozymes alleviate doxorubicin-induced cardiotoxicity by restraining oxidative stress associated with Nrf2 signaling. Journal of Colloid and Interface Science. 2025;686:1074-1088. doi:10.1016/j.jcis.2025.02.033
BibTeX
@article{Wang2025,
author = {Wang, Fang and Wang, Ke and Fang, BaoRu and Geng, SiQi and Li, Ying and Qian, HuiFeng and Lin, YiNuo and Yu, ZhangSen},
title = {Hollow mesoporous Prussian blue nanozymes alleviate doxorubicin-induced cardiotoxicity by restraining oxidative stress associated with Nrf2 signaling},
journal = {Journal of Colloid and Interface Science},
year = {2025},
volume = {686},
pages = {1074--1088},
doi = {10.1016/j.jcis.2025.02.033}
}
EUVIMED